{"id":889,"date":"2025-12-19T20:05:04","date_gmt":"2025-12-19T20:05:04","guid":{"rendered":"https:\/\/cpmiclinical.com\/?p=889"},"modified":"2026-04-21T23:55:57","modified_gmt":"2026-04-21T23:55:57","slug":"year-end-in-early-phase-what-weve-learned-whats-next","status":"publish","type":"post","link":"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/","title":{"rendered":"Fin de a\u00f1o en fase temprana: Lo que hemos aprendido y lo que sigue"},"content":{"rendered":"<p><strong>Reflexionando sobre nuestros hitos<\/strong><\/p>\n\n\n\n<p>2025 ha sido un a\u00f1o clave para nuestro equipo de investigaci\u00f3n en fase inicial. Desde <strong>estudios realizados por primera vez en humanos (FIH)<\/strong> a ensayos especializados en <strong>insuficiencia hep\u00e1tica y renal<\/strong>, y a\u00fan <strong>Evaluaciones de responsabilidad por abuso humano (HAL)<\/strong>, Hemos avanzado en la ciencia para acercar nuevas terapias a los pacientes que m\u00e1s las necesitan. Estos estudios son la base del desarrollo de f\u00e1rmacos, donde se comprenden primero la seguridad, la tolerabilidad y la farmacocin\u00e9tica antes de que una terapia avance.<\/p>\n\n\n\n<p>Nuestro centro complet\u00f3 con \u00e9xito m\u00faltiples programas de FIH, ayudando a los patrocinadores a definir estrategias de dosificaci\u00f3n seguras e identificar se\u00f1ales tempranas de eficacia. En estudios hep\u00e1ticos y renales, aplicamos dise\u00f1os adaptativos y modelos farmacocin\u00e9ticos para garantizar recomendaciones de dosificaci\u00f3n precisas para poblaciones a menudo excluidas de los ensayos tradicionales. Los estudios HAL proporcionaron datos cruciales para orientar las decisiones regulatorias y proteger la salud p\u00fablica.<\/p>\n\n\n\n<p><strong>Un sincero agradecimiento a nuestros voluntarios<\/strong><\/p>\n\n\n\n<p>Ninguno de estos avances ser\u00eda posible sin las personas que se ofrecieron como voluntarias para estos ensayos cl\u00ednicos en fase inicial. Su participaci\u00f3n es la clave para que los nuevos medicamentos puedan avanzar de forma segura y \u00e9tica. Cada dato aportado ayuda a los investigadores a responder preguntas vitales:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00bfEs esta terapia segura para los humanos?<\/li>\n\n\n\n<li>\u00bfC\u00f3mo se comporta en el organismo?<\/li>\n\n\n\n<li>\u00bfQu\u00e9 dosis es segura y efectiva?<\/li>\n<\/ul>\n\n\n\n<p>Su compromiso acelera la innovaci\u00f3n y, en \u00faltima instancia, salva vidas.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"538\" src=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-1024x538.jpg\" alt=\"\" class=\"wp-image-891\" srcset=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-1024x538.jpg 1024w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-300x158.jpg 300w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-768x403.jpg 768w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-1536x806.jpg 1536w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-2048x1075.jpg 2048w, https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/December-Blog-Graphics_Phase-1-2-18x9.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Tendencias emergentes para 2026<\/strong><\/p>\n\n\n\n<p>El futuro de la investigaci\u00f3n en fase temprana est\u00e1 siendo determinado por <strong>tecnolog\u00eda y ciencia de precisi\u00f3n<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>IA y modelado predictivo<\/strong>La inteligencia artificial est\u00e1 optimizando el dise\u00f1o de ensayos, la selecci\u00f3n de pacientes y la predicci\u00f3n de dosis, reduciendo los plazos y mejorando la seguridad.<\/li>\n\n\n\n<li><strong>Estrategias basadas en biomarcadores<\/strong>Los biomarcadores est\u00e1n reemplazando los puntos finales tradicionales, lo que permite una selecci\u00f3n de dosis m\u00e1s inteligente y una estratificaci\u00f3n de los pacientes.<\/li>\n\n\n\n<li><strong>Dise\u00f1os adaptativos y descentralizados<\/strong>Los ensayos se est\u00e1n volviendo m\u00e1s flexibles y centrados en el paciente, incorporando monitoreo remoto y datos del mundo real.<\/li>\n\n\n\n<li><strong>Resultados informados por el paciente (PRO)<\/strong>Incluso en ensayos de oncolog\u00eda y enfermedades raras en fase temprana, los PRO est\u00e1n ganando importancia para garantizar que las terapias mejoren la calidad de vida, no solo los valores de laboratorio.<\/li>\n<\/ul>\n\n\n\n<p>Estas innovaciones prometen aprobaciones m\u00e1s r\u00e1pidas, dosificaciones m\u00e1s seguras e investigaciones m\u00e1s inclusivas.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Reflexionando sobre nuestros logros. 2025 ha sido un a\u00f1o clave para nuestro equipo de investigaci\u00f3n en fase inicial. Desde estudios pioneros en humanos (FIH) hasta ensayos especializados en insuficiencia hep\u00e1tica y renal, e incluso evaluaciones de riesgo de abuso humano (HAL), hemos avanzado en la ciencia para acercar las nuevas terapias a los pacientes que m\u00e1s las necesitan. Estos estudios son la base... <\/p>\n<p class=\"read-more-container\"><a title=\"Fin de a\u00f1o en fase temprana: Lo que hemos aprendido y lo que sigue\" class=\"read-more button\" href=\"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/#more-889\" aria-label=\"Leer m\u00e1s sobre Fin de a\u00f1o en fase temprana: lo que hemos aprendido y lo que sigue\">Lee mas<\/a><\/p>","protected":false},"author":9,"featured_media":933,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[],"class_list":["post-889","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-en","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next - Clinical Pharmacology of Miami<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next - Clinical Pharmacology of Miami\" \/>\n<meta property=\"og:description\" content=\"Reflecting on Our Milestones 2025 has been a landmark year for our early-phase research team. From first-in-human (FIH) studies to specialized trials in hepatic and renal impairment, and even Human Abuse Liability (HAL) assessments, we\u2019ve advanced science in ways that bring new therapies closer to patients who need them most. These studies are the foundation ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Pharmacology of Miami\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-19T20:05:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T23:55:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dylan Bahe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dylan Bahe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/\"},\"author\":{\"name\":\"Dylan Bahe\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/1537d14f60060f10f99e58982bb18dad\"},\"headline\":\"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next\",\"datePublished\":\"2025-12-19T20:05:04+00:00\",\"dateModified\":\"2026-04-21T23:55:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/\"},\"wordCount\":316,\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/\",\"name\":\"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next - Clinical Pharmacology of Miami\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp\",\"datePublished\":\"2025-12-19T20:05:04+00:00\",\"dateModified\":\"2026-04-21T23:55:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp\",\"width\":1500,\"height\":788,\"caption\":\"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/year-end-in-early-phase-what-weve-learned-whats-next\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cpmiclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"name\":\"Clinical Pharmacology of Miami\",\"description\":\"Clinical research in Miami \\\/ Hialeah, FL\",\"publisher\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cpmiclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#organization\",\"name\":\"Clinical Pharmacology of Miami\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"contentUrl\":\"https:\\\/\\\/cpmiclinical.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/CPMI-Blue-Logo-copy.webp\",\"width\":150,\"height\":134,\"caption\":\"Clinical Pharmacology of Miami\"},\"image\":{\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cpmiclinical.com\\\/#\\\/schema\\\/person\\\/1537d14f60060f10f99e58982bb18dad\",\"name\":\"Dylan Bahe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g\",\"caption\":\"Dylan Bahe\"},\"url\":\"https:\\\/\\\/cpmiclinical.com\\\/es\\\/author\\\/dylanb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fin de a\u00f1o en fase temprana: Lo que hemos aprendido y lo que sigue - Farmacolog\u00eda Cl\u00ednica de Miami","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/","og_locale":"es_MX","og_type":"article","og_title":"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next - Clinical Pharmacology of Miami","og_description":"Reflecting on Our Milestones 2025 has been a landmark year for our early-phase research team. From first-in-human (FIH) studies to specialized trials in hepatic and renal impairment, and even Human Abuse Liability (HAL) assessments, we\u2019ve advanced science in ways that bring new therapies closer to patients who need them most. These studies are the foundation ... Read more","og_url":"https:\/\/cpmiclinical.com\/es\/year-end-in-early-phase-what-weve-learned-whats-next\/","og_site_name":"Clinical Pharmacology of Miami","article_published_time":"2025-12-19T20:05:04+00:00","article_modified_time":"2026-04-21T23:55:57+00:00","og_image":[{"width":1500,"height":788,"url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp","type":"image\/webp"}],"author":"Dylan Bahe","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dylan Bahe","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#article","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/"},"author":{"name":"Dylan Bahe","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/1537d14f60060f10f99e58982bb18dad"},"headline":"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next","datePublished":"2025-12-19T20:05:04+00:00","dateModified":"2026-04-21T23:55:57+00:00","mainEntityOfPage":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/"},"wordCount":316,"publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"image":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp","articleSection":["Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/","url":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/","name":"Fin de a\u00f1o en fase temprana: Lo que hemos aprendido y lo que sigue - Farmacolog\u00eda Cl\u00ednica de Miami","isPartOf":{"@id":"https:\/\/cpmiclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#primaryimage"},"image":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#primaryimage"},"thumbnailUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp","datePublished":"2025-12-19T20:05:04+00:00","dateModified":"2026-04-21T23:55:57+00:00","breadcrumb":{"@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#primaryimage","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2025\/12\/Year-End-in-Early-Phase-\u2013-What-Weve-Learned-Whats-Next.webp","width":1500,"height":788,"caption":"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next"},{"@type":"BreadcrumbList","@id":"https:\/\/cpmiclinical.com\/year-end-in-early-phase-what-weve-learned-whats-next\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cpmiclinical.com\/"},{"@type":"ListItem","position":2,"name":"Year-End in Early Phase \u2013 What We\u2019ve Learned, What\u2019s Next"}]},{"@type":"WebSite","@id":"https:\/\/cpmiclinical.com\/#website","url":"https:\/\/cpmiclinical.com\/","name":"Clinical Pharmacology of Miami","description":"Investigaci\u00f3n cl\u00ednica en Miami \/ Hialeah, FL","publisher":{"@id":"https:\/\/cpmiclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cpmiclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/cpmiclinical.com\/#organization","name":"Clinical Pharmacology of Miami","url":"https:\/\/cpmiclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","contentUrl":"https:\/\/cpmiclinical.com\/wp-content\/uploads\/2026\/02\/CPMI-Blue-Logo-copy.webp","width":150,"height":134,"caption":"Clinical Pharmacology of Miami"},"image":{"@id":"https:\/\/cpmiclinical.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cpmiclinical.com\/#\/schema\/person\/1537d14f60060f10f99e58982bb18dad","name":"Dylan Bahe","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0c1ae25cfb43c40e7dcb83bf283642be6020d8fa2a2836a7886c2d8ff6fb83f3?s=96&d=mm&r=g","caption":"Dylan Bahe"},"url":"https:\/\/cpmiclinical.com\/es\/author\/dylanb\/"}]}},"_links":{"self":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/comments?post=889"}],"version-history":[{"count":0,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/posts\/889\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media\/933"}],"wp:attachment":[{"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/media?parent=889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/categories?post=889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cpmiclinical.com\/es\/wp-json\/wp\/v2\/tags?post=889"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}